This is especially important since AR-independent forms of prostate cancer may be increasing in frequency19, and a recent report demonstrated that MYC was an essential gene for driving progression of normal basal prostatic epithelial cells to AR-independent, neuroendocrine tumors that have features similar to clinical neuroendocrine prostate cancer20. The gene discussed is MYC; the disease is prostate carcinoma.